Publicaciones (354) Publicaciones de MARIA PAZ GARCIA-PORTILLA GONZALEZ

2024

  1. Aprendizaje y memoria verbal: comparación entre pacientes con trastorno por consumo de alcohol y trastorno de depresión mayor

    Adicciones: Revista de socidrogalcohol, Vol. 36, Núm. 1, pp. 21-30

  2. Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation

    Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338

  3. Diurnal cortisol throughout pregnancy and its association with maternal depressive symptoms and birth outcomes

    Psychoneuroendocrinology, Vol. 161

  4. From gut to brain: A network model of intestinal permeability, inflammation, and psychotic symptoms in schizophrenia.

    European Neuropsychopharmacology, Vol. 79, pp. 32-37

  5. Impact of cognitive reserve in clinical, neurocognitive and lifestyle factors in chronic schizophrenia and early stages of schizophrenia

    Spanish Journal of Psychiatry and Mental Health

  6. Impacto del consumo de sustancias sobre la permeabilidad intestinal en pacientes con esquizofrenia

    Adicciones: Revista de socidrogalcohol, Vol. 36, Núm. 1, pp. 111-114

  7. Intestinal permeability and low-grade chronic inflammation in schizophrenia: A multicentre study on biomarkers. Rationale, objectives, protocol and preliminary results

    Spanish Journal of Psychiatry and Mental Health

  8. Non-binary gender, vulnerable populations and mental health during the COVID-19 pandemic: Data from the COVID-19 MEntal health inTernational for the general population (COMET-G) study

    Journal of Affective Disorders, Vol. 352, pp. 536-551

  9. Platelet and white blood-cell-based ratios: Differential inflammatory markers of severe mental disorders?

    Spanish Journal of Psychiatry and Mental Health

  10. Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms

    Molecular Psychiatry

  11. Rural residence and health-related quality of life in a sample of Spain perimenopausal women

    Gynecological Endocrinology, Vol. 40, Núm. 1

  12. Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study)

    CNS Spectrums, Vol. 29, Núm. 2, pp. 126-149

2023

  1. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

  2. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  3. Differential Cellular Interactome in Schizophrenia and Bipolar Disorder—Discriminatory Biomarker Role

    Antioxidants, Vol. 12, Núm. 11

  4. Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis

    Psychological Medicine

  5. Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study

    Neuropsychiatric Disease and Treatment, Vol. 19, pp. 895-906

  6. Emotional intelligence: A comparison between patients after first episode mania and those suffering from chronic bipolar disorder type i

    Psychological Medicine, Vol. 53, Núm. 7, pp. 3065-3076

  7. Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    Psychiatry Research, Vol. 323

  8. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients

    Revista de Psiquiatria y Salud Mental